VPIM
APLT

Vanguard Personalized Indexing Management’s Applied Therapeutics APLT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,244
Closed -$9.83K – 1987
2025
Q3 		$9.83K Buy
16,244
+4,623
+40% +$2.18K ﹤0.01% 1978
2025
Q2 		$3.62K Sell
11,621
-1,612
-12% -$624 ﹤0.01% 1940
2025
Q1 		$6.47K Buy
+13,233
New +$7.79K ﹤0.01% 1829
2022
Q2 		– Sell
-20,119
Closed -$42K – 1265
2022
Q1 		$42K Buy
+20,119
New +$53.9K ﹤0.01% 1189

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Personalized Indexing Management's APLT Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 16,244 shares — an estimated $9.83K sold.

Vanguard Personalized Indexing Management first reported a position in APLT in Q1 2022 and held it in 4 quarters. The position peaked at $42K in Q1 2022. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 16,244 Applied Therapeutics shares in Q4 2025, an estimated $9.83K.
  • Vanguard Personalized Indexing Management first reported a position in Applied Therapeutics in Q1 2022 and held it in 4 quarters.
  • Vanguard Personalized Indexing Management's Applied Therapeutics position peaked at $42K in Q1 2022.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.